www.summitMD.com

Update : August 22, 2008

	Left main coronary disease

	Ostial disease

	Bifurcation

	Graft vessel disease

	Diffuse coronary disease

	Chronic total occlusion (CTO)

	Restenosis

	Multivessel disease

	Drug eluting stent

	Vulnerable plaque

Angioplasty Summit 2005

: Expert Lectures

Abstracts

Poster Abstracts -
Guidelines -

Oral Abstracts -
Guidelines -

--Thursday, April 28
-	Drug Eluting Stent Summit-I
-	New Clinical Trials Updates 2005 - from TCT, AHA, ACC
-	The Future of DES and Complex PCI
-	Virtual Histology; Beyond IVUS
-	"ENDEAVOR"- What's New ? What's Different ?
-	Is Cypher the Best Choice? - Clinical Perspectives of Cypher
--Friday, April 29
-	Plenary Sessions
-	Vulnerable Plaque
-	Bifurcation Lesions
-	Drug Eluting Stent Summit - II
-	Acute Myocardial Infarction
-	Chronic Total Occlusions
-	Complex PCI
-	Angiomygenesis
-	Current Standards and Proposed Directions in Pharmacologic Approaches for PCI
-	Lipid Management : A New Era in The Treatment of Coronary Artery Disease
-	Drug Eluting Stent Summit - III
-	"Reducing Cardiovascular Risk" Keyword in Managing Hypertension and Lipid
--Saturday, April 30
-	Plenary Sessions
-	EuroPCR Session
-	Left Main Lesions
-	Drug Eluting Stent Summit - IV
-	Management of Complications
-	IVUS, OCT, Thrombectomy, Atherectomy, and Cutting
-	Peripheral Lesions
-	Why not TRI ?
-	Promise of Glitazone
-	Advanced Endovascular Therapy: Cordis Clinical Results on Renal and SFA Stenting

Drug Eluting Stent Summit-I

•	DES Pathobiology Considerations: What We Know and What We Don't Know Can Hurt Us!
	-Presenter : Renu Virmani, MD

•	Late Loss Remains the Best Single Indicator of DES Performance
	-Presenter : Richard E. Kuntz , MD

•	Is the TAXUS Stent Benefit Extended to the Most Complicated Patients and Lesions?
	-Presenter : Eberhard Grube, MD

•	New Drug Eluting Stents
	-Presenter : Alexandre Abizaid, MD

•	Are All Sirolimus Analogs Alike?
	-Presenter : Robert Falotico, MD

•	Paclitaxel-Eluting TAXUS Stents Strengths and Weaknesses
	- Presenter : Gregg W. Stone, MD

•	The "Appropriate" Use of IVUS During DES Procedures
	- Presenter : Gary S. Mintz, MD

Drug Eluting Stent Summit-II

•	DES for Bifurcation Lesion
	- Presenter: Yean-Teng Lim, MD

•	DES for Complex Patients Subsets
	- Presenter: Alexandre Abizaid, MD

•	Everolimus Drug-Eluting Stents I: Review of Guidant FUTURE I and II, and Status Update of FUTURE III and IV
	- Presenter: Eberhard Grube, MD

•	ZoMaxx: Abbott's Drug Eluting Stent Program
	- Presenter: John Ormiston, MD

Drug Eluting Stent Summit-III

•	Drug-Eluting Biodegradable Igaki-Tamai Stent
	- Presenter: Hideo Tamai, MD

•	Update on the Endeavor I-V Trials: The Latest Results
	- Presenter: Ian T. Meredith, MD

•	Terumo DES Program -Nobori 1 Clinical Trial
	- Presenter: Hidehiko Honda, MD

•	Update on Jupiter l and ll Clinical Trials with the Sorin Carbostent Tacrocimus Eluting Stent
	- Presenter: Gian Battista Danzi, MD

Drug Eluting Stent Summit-IV

•	ABT 578 Drug-Eluting Stents II: Preclinical Observations and the Clinical Trial Strategy for the Abbott ZoMax Stent
	- Presenter: Alan C. Yeung, MD

•	Reopro Eluting Stents in Acute Coronary Syndrome
	- Presenter: Myung-Ho Jeong, MD

•	Cypher PK study in Japan
	- Presenter: Masato Nakamura, MD

New Clinical Trials Updates 2005 - from TCT, AHA, ACC

•	The Biolimus A9 DES Program (Focus on Stealth 1)
	-Presenter : Eberhard Grube , MD

•	The Endeavor DES Program (Focus on Endeavor 2)
	-Presenter : Richard E. Kuntz, MD

•	Recent Updates from the Cypher Trials (Cypher Meta-Analysis, Diabetes, Late FU from FIM and SIRIUS, ARTS II)
	-Presenter : Alexandre Abizaid , MD

•	Recent Updates from the Taxus Trials (Taxus 2 and 4 Late FU, Taxus Meta-Analysis, and Taxus 5)
	-Presenter : Gregg W. Stone, MD

The Future of DES and Complex PCI

•	Taxus V Clinical Update
	-Presenter : Gregg W. Stone, MD

•	Diabetic Performance in Taxus
	-Presenter : Myung-Ho Jeong, MD

•	IVUS in Complex PCI
	-Presenter : Alan C. Yeung, MD

•	Pre & Post-Dilatation Strategies for DES
	-Presenter : Ted Feldman, MD

Virtual Histology; Beyond IVUS

•	Virtual History: Concept and Validation
	-Presenter : D. Geoffrey Vince, MD

•	Virtual Histology- A Technical & Clinical Update
	-Presenter : Gary S. Mintz, MD

•	Real World Paradigm for Identifying Vulnerable Plaques and Vulnerable Patients
	-Presenter : James R. Margolis, MD

"ENDEAVOR"- What's New ? What's Different ?

•	Overview of Endeavor II Clinical Results
	-Presenter : Ian T. Meredith, MD

•	Safety and Endeavor II Subsets
	-Presenter : Richard E. Kuntz, MD

Is Cypher the Best Choice? - Clinical Perspectives of Cypher

•	REALITY Head-To-Head Comparison
	-Presenter : Alexandre Abizaid, MD

•	Safety and Efficacy of Cypher on Complex Lesion
	-Presenter : Seung-Jung Park, MD

•	Is Sirolimus Different from Analogues?
	-Presenter : Robert Falotico, MD

Plenary Sessions

•	The E-valve Edge-to-Edge Repair for Mitral Regurgitation: Design Concept and EVEREST Update
	-Presenter : Ted Feldman, MD

•	New Concept and Device for Ostial and Bifurcation Stenting
	-Presenter : Yaron Almagor, MD

•	Percutaneous Interventions for Patent Foramen Ovale
	-Presenter : Eric Eeckhout, MD

•	Evidence-Based Medicine Analysis of Current DES Clinical Use Guidelines: A Roadmap for Clinicians
	-Presenter : Gregg W. Stone, MD

•	Plaque Progression and Regression
	-Presenter : James R. Margolis, MD

•	What Are the Proper End Points for DES Trials?
	-Presenter : Alan C. Yeung, MD

•	Drug-Eluting Stents, Late Loss, and Restenosis DES to Prevent MIs
	-Presenter : Richard E. Kuntz, MD

•	Peripheral Vascular Interventions: What Is Possible in 2005 ?
	-Presenter : Gerald Dorros, MD

•	Renal Stenting: ASPIRE II , Update on Resist and CORAL Trial Status
	-Presenter : Krishna Rocha-Singh, MD

•	SFA Interventions (Including New Technique, CTO)
	-Presenter : Krishna Rocha-Singh, MD

•	Virtual Histology - A Technical and Clinical Update
	-Presenter : Gary S. Mintz, MD

•	Pathology of Vulnerable Plaque
	-Presenter : Renu Virmani, MD

Vulnerable Plaque

•	Erosion, Intraplaque Hemorrhage: The Other Face of Vulnerability
	-Presenter : Renu Virmani, MD

•	Characterization of Coronary Atherosclerotic Plaques Using CTA
	-Presenter : Koen Nieman, MD

•	Coronary Artery Thermography
	-Presenter : Christodoulos Stefanadis, MD

•	Detection and Treatment of Thin Fibrous Cap, Lipid Rich, and Inflammatory Vulnerable Plaque - Angioscopic Evaluation
	-Presenter : Kyoichi Mizuno, MD

•	Epidemiologic Stent-Based Approach to Vulnerable Plaque Stabilization Based on Statistical Modeling of Plaque Rupture and Death
	-Presenter : Richard E. Kuntz, MD

•	Regional Photodynamic Therapy for Vulnerable Plaque Stabilization I: Antrin
	-Presenter : Alan C. Yeung, MD

Bifurcation Lesions

•	Bench Insights into Bifurcation Stenting Strategies. An Update
	- Presenter: John Ormiston, MD

•	Efficacy of FX Minirail Balloon in Bifurcation Lesions
	Presenter: Junbo Ge, MD

Acute Myocardial Infarction

•	EMERALD Trial: Lessons Learned
	- Presenter: Gregg W. Stone, MD

•	Final Results of ASPARAGAS Study
	- Presenter: Toshiya Muramatsu, MD

•	Coronary Flow Pattern and Myocardial Viability: Comparison with PET
	- Presenter: Seung-Jea Tahk, MD

•	Multivessel versus Single-vessel Angioplasty During Acute MI
	- Presenter: Mun Kyung Hong, MD

Chronic Total Occlusions

•	Coated vs Non-Coated Wires for CTO
	- Presenter: James R. Margolis, MD

•	Long Term Outcome of 1,000 CTO Cases
	- Presenter: Toshiya Muramatsu, MD

•	Zen Philosophy - The KEY to CTO Success
	- Presenter: Gregg W. Stone, MD

Complex PCI

•	Drug Eluting Stents in CTO
	- Presenter: Kenneth Chin, MD

•	Cypher - LAD Ostial Lesions; No More Surgery !
	- Presenter: Ki Bae Seung, MD

Angiomygenesis

•	Angiogenesis Mediated by Adipose-Derived Stromal Cells: How Fat Can Be Good
	- Presenter: Keith L. March, MD

Current Standards and Proposed Directions in Pharmacologic Approaches for PCI

•	Optimizing Outcomes of Primary PCI: From CADILLAC to HORIZONS
	- Presenter: Gregg W. Stone , MD

Lipid Management : A New Era in The Treatment of Coronary Artery Disease

•	The TNT Trial: Is It Time to Shift Our Goals in Clinical Practice
	- Presenter: David Colquhoun, MD

•	Early Statin Therapy in Acute Coronary Syndrome
	- Presenter: Cheol-Whan Lee, MD

•	Beyond the Statin Therapy: The Importance of HDL Cholesterol
	- Presenter: Ki Hoon Han, MD

"Reducing Cardiovascular Risk" Keyword in Managing Hypertension and Lipid

•	Mechanisms Linking Angiotensin II & Atherogenesis
	- Presenter: Carlos M. Ferrario, MD

EuroPCR Session

•	Lesson Learnt During Live Cases Transmission at EuroPCR 2004
	- Presenter: Jean Fajadet, MD

•	The Future Role of the Cardiologist in Extracardiac Intervention
	- Presenter: Giancarlo Biamino, MD

•	Clinical Relevance of Stent Fractures in the Treatment of SFA Lesion
	- Presenter: Giancarlo Biamino, MD

•	Lesson Learnt in the Complication Session at EuroPCR 2004
	- Presenter: Eric Eeckhout, MD

Left Main Lesions

•	Medium Term Follow-up of Drug-Eluting Stents in Left Main Bifurcation Stenosis
	- Presenter: Teguh Santoso, MD

•	Management of Non-Protected Left Main Bifurcation Without DES
	- Presenter: Masahiko Ochiai, MD

•	LM stenting -Cypher
	- Presenter: Seung-Jung Park, MD

•	LM stenting -TAXUS
	- Presenter: Marc Silvestri, MD

Management of Complications

•	Treatment for No Reflow
	- Presenter: Mark Simmonds, MD

•	Coronary Artery Perforations
	- Presenter: James R. Margolis, MD

•	Transcatheter Closure of Post Acute Myocardial Infarction Ventricular Septal Rupture: Issues and Controversies
	- Presenter: Ajit Sankardas Mullasari, MD

IVUS, OCT, Thrombectomy, Atherectomy, and Cutting

•	IVUS Guide PCI at Acute Coronary Syndrome
	- Presenter: Motomaru Masutani, MD

•	Arterial Plaque Evaluation Using OCT: A Comparison with IVUS and Histological Findings
	- Presenter: Takashi Akasaka, MD

•	The Role of Atherectomy Devices in the Real DES Era
	- Presenter: Etsuo Tsuchikane, MD

Peripheral Lesions

•	Trans-Radial Approach Renal Stenting
	- Presenter: Chiung-Jen Wu, MD

•	The Upsurge in Renal Revascularization: Cosmetic or Clinically Relevant?
	- Presenter: Giancarlo Biamino, MD

•	Carotid Angioplasty is the treatment of Choice for Obstructive Carotid Bifurcation Disease
	- Presenter: Gerald Dorros, MD

Why not TRI

•	TRI for Complex Lesion
	- Presenter: Motomaru Masutani, MD

•	Results of Radial Artery Intervention in >11,000 Patients: A 10-Year Experience
	- Presenter: Jean Fajadet, MD

•	Trans-Radial Intervention for Chronic Total Occlusion
	- Presenter: Takaaki Shiono, MD

•	Changes in the Diameter of the Radial Artery After TRA or TRI
	- Presenter: Yoshifumi Kan, MD

•	Why not TRI in Acute Coronary Syndrome
	- Presenter: Junghan Yoon, MD

•	TRI for Acute Myocardial Infarction in Kyoto, Report from the Registration of Kyoto AMI Conference
	- Presenter: Takashi Okada, MD

Promise of Glitazone

•	Inflammation: Novel Target for Cardiovascular Risk Reduction
	- Presenter: Andrew Zalewski, MD

•	The Promise of the Thiazolidinediones in the Management of Type 2 Diabetes-Associated Cardiovascular Disease
	- Presenter: Stephen Alistair Smith, MD

•	Preventative Effects of Rosiglitazone on Restenosis after Coronary Stent Implantation
	- Presenter: Dong Hoon Choi, MD

Advanced Endovascular Therapy: Cordis Clinical Results on Renal and
SFA Stenting

•	Asian Perspective-Takayasu Disease and Renal Stenting
	- Presenter: Mohd Ali Rosli, MD

•	SFA Stenting: BLASTER Study
	- Presenter: Krishna Rocha-Singh, MD